Regulatory Aspects and Their Influence on Pharmaceutical Research and on the Introduction of Drugs in Canada

The document details the background to the present regulatory environmentand asseses the need for new regulations and guidelines. It makes a numberof recommendations, pertaining to new drugs vs old drugs, drug scheduling, pharmaceutical chemistry, product monographs, toxicological requirements, clinical research, drug approval, orphaned drugs, and other issues.